Skip to main content
Livermore
Livermore
ZHEN

Lakefront Biotherapeutics NV

LKFT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001421876

No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.

Other share classesGLPGF

Q2 2021 vs. Q1 2021

How the institutions holding Lakefront Biotherapeutics NV changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of LKFT: Q1 2021 compared with Q2 2021
MeasureQ1 2021Of which not filed for Q2 2021Q2 2021Change
Holders1332109−22
Shares6.57M8.70K7.51M+950.0K (+14.5%)
Value$506.0M$671.0K$517.2M+$11.9M (+2.4%)

2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Lakefront Biotherapeutics NV at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to LKFT in Q2 2021
InstitutionSharesValue% of portfolio
Deerfield Management Company, L.P. (Series C)657,005$45.3M0.80%
Ghost Tree Capital, LLC75,000$5.17M1.62%
Ghisallo Capital Management LLC48,731$3.36M0.13%
683 Capital Management, LLC33,323$2.30M0.11%
Caas Capital Management LP32,869$2.26M0.12%
Optiver Holding B.V.14,721$1.01M0.14%
Highland Capital Management Fund Advisors, L.P.14,000$964.0K0.21%
Aigen Investment Management, LP4,963$342.0K0.06%
Trexquant Investment LP3,939$271.0K0.02%
Advisory Services Network, LLC1,050$72.0K0.00%
Wealth Quarterback LLC264$19.0K0.01%
Column Capital Advisors, LLC19$1.00K0.00%
Glassman Wealth Services4$00.00%

Sold out (35)

Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of LKFT in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Federated Hermes, Inc.165,000$12.7M
Susquehanna International Securities, Ltd.21,700$1.67M
Capital Fund Management S.A.19,223$1.48M
Acadian Asset Management LLC14,087$1.09M
Stifel Financial Corp12,560$968.0K
Baker Bros. Advisors LP11,180$862.0K
Stonepine Capital Management, LLC10,000$771.0K
Bank of New York Mellon Corp8,327$642.0K
First Republic Investment Management, Inc.5,821$449.0K
Raymond James & Associates5,701$439.0K
United Capital Financial Advisers, LLC5,488$423.0K
Crossmark Global Holdings, Inc.5,476$422.0K
FDx Advisors, Inc.4,247$327.0K
Avoro Capital Advisors LLC3,100$239.0K
Lumina Fund Management LLC3,000$231.0K
LVW Advisors, LLC2,938$226.0K
Quantbot Technologies LP2,300$177.0K
Geneos Wealth Management Inc.1,638$127.0K
Shay Capital LLC610$47.0K
RMR Wealth Builders434$33.0K
Standard Family Office LLC429$33.0K
Private Capital Group, LLC270$21.0K
Lumature Wealth Partners, LLC269$21.0K
Bank of Montreal174$14.0K
Bessemer Group Inc163$13.0K
Harbor Investment Advisory, LLC159$12.0K
American Portfolios Advisors110$8.48K
Sowell Financial Services LLC79$6.00K
Fifth Third Bancorp51$4.00K
International Assets Investment Management, LLC44$4.00K
FourThought Financial, LLC52$4.00K
Front Row Advisors LLC32$2.00K
Eudaimonia Partners, LLC17$1.00K
Raffa Wealth Management, LLC3$231
Fieldpoint Private Securities, LLC5$0

Not filed for Q2 2021 yet (2)

Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LKFT in Q1 2021 that haven't filed for Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
OneAscent Wealth Management LLC5,974$461.0K
OneAscent Financial Services LLC2,723$210.0K